Indacaterol is prescribed for:
- COPD maintenance treatment
- Chronic bronchitis
- Emphysema
- Respiratory disease management
Specifically approved for COPD, not asthma.
Generic Name: Indacaterol Maleate
Brand Names: Arcapta Neohaler
Indacaterol is a once-daily ultra-long-acting beta-agonist for maintenance treatment of COPD.
Indacaterol is prescribed for:
Specifically approved for COPD, not asthma.
Common side effects:
Serious side effects:
Indacaterol is an ultra-long-acting beta-agonist for COPD.
Unlike some LABAs, indacaterol is approved only for COPD, not for asthma.
Has faster onset than salmeterol (5 minutes), similar to formoterol, with 24-hour duration.
Learn more at MedlinePlus.
This medication is commonly used to treat or manage the following conditions:
Asthma, a chronic lung disease, causes airway inflammation and narrowing, resulting in wheezing, coughing, and shortness of breath, triggered by allergens, irritants, infections, or stress.
COPD, a progressive lung disease causing irreversible airflow limitation, encompassing emphysema and chronic bronchitis, is primarily driven by irritant exposure like smoking, leading to shortness of breath and chronic cough.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Have questions about Indacaterol? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.